Digital Therapeutic (DTx) Market by Application (Prediabetes, Nutrition, Care, Diabetes, CVD, CNS, CRD, MSD, GI, Substance Abuse, Rehabilitation), Sales Channel (B2C, Patient, Caregiver, B2B, Providers, Payer, Employer, Pharma) – Global forecasts to 2025

2020-03-20
Price :
Published : Mar-2020
No. of Pages : 166

“Growing incidence of preventable chronic diseases and the need to control healthcare costs are the key factors driving the growth of the digital therapeutics market.”

The global digital therapeutics market is projected to reach USD 6.9 billion by 2025 from USD 2.1 billion in 2020, at a CAGR of 26.7% during the forecast period. Growth in this market is mainly driven by the growing incidence of preventable chronic diseases, the need to control healthcare costs, and rising investments in digital therapeutics. On the other hand, a lack of awareness and access to digital therapeutics programs in developing countries, resistance from traditional healthcare providers, and unstable payment models are challenging the growth of this market.

Treatment/care-related applications segment accounted for the largest share of the digital therapeutics market in 2019

Based on application, the digital therapeutics market is segmented into preventive and treatment/care-related applications.Rising healthcare costs, the growing prevalence of chronic diseases, and the ability of digital therapeutics to provide cost-effective solutions are some factors responsible for driving the market for treatment/care-related digital therapeutics applications.

Diabetes segment is expected to dominate the market

Based on the type of treatment/care-related application, the digital therapeutics market is further segmented into diabetes, CNS disorders, chronic respiratory diseases, musculoskeletal disorders, cardiovascular diseases, smoking cessation, medication adherence, gastrointestinal disorders, substance use disorders & addiction management, rehabilitation & patient care, and other treatment/care-related applications. The diabetes segment accounted for the largest share of the digital therapeutics market. The large share of this segment is attributed to the growing prevalence of diabetes across the globe. In addition, government initiatives to reduce the burden of diabetes using digital health are responsible for the large share of this segment.

B2B segment is expected to grow at the highest CAGR during the forecast period.

Based on the sales channel, the digital therapeutics market is segmented into business-to-customer (B2C) and business-to-business (B2B). The B2B segment is the largest and fastest-growing segment of the digital therapeutics market. The high preference of pharmaceutical companies to integrate digital therapeutics with their drug products to offer adherence services is a key factor driving the growth of this segment. Furthermore, rising awareness among payers, employers, and providers about the benefits of digital therapeutics has also supported the market growth.

North America to be the largest and the fastest-growing regional market

North America, which comprises the US and Canada, forms the largest market for digital therapeutics. The US is home to a plethora of digital therapeutics start-ups. In addition, government initiatives to support technological advancements, improvements in the reimbursement structure for digital therapeutics, and the increasing investments in digital therapeutics are responsible for the high growth of digital therapeutics in North America.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 (50%), Tier 2 (30%), and Tier 3 (20%)
  • By Designation: C-level (75%), D-level (15%), and Others (10%)
  • By Region: North America (70%), Europe (20%), APAC (7%), and the RoW (3%)

List of Companies Profiled in the Report

  • Noom (US)
  • Livongo Health (US)
  • Omada Health (US)
  • WellDoc (US)
  • Pear Therapeutics (US)
  • Proteus Digital Health (US)
  • Propeller Health (US)
  • Akili Interactive Labs (US)
  • Better Therapeutics (US)
  • Happify (US)
  • Kaia Health (Germany)
  • Mango Health (US)
  • Click Therapeutics (US)
  • Canary Health (US)
  • Wellthy Therapeutics (India)
  • Cognoa (US)
  • Ayogo Health (Canada)
  • Mindstrong Health (US)
  • 2Morrow (US)
  • Ginger (US)

Research Coverage:

This report provides a study of the digital therapeutics market. It aims at estimating the size and future growth potential of the market across different segments, such as sales channel, application, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of revenue numbers for the overall digital therapeutics market and its sub segments. This report will also help stakeholders understand the competitive landscape, gain insights to position their business,and make suitable go-to-market strategies. It will also enable stakeholders to gauge the pulse of the market and provide them with information on the key market drivers, restraints, challenges, and opportunities.

Filed in: Medical Device
Publisher : marketsandmarkets
More Reports
Title Price Buy Now

Cardiac Monitoring & Cardiac Rhythm Management Devices Market By Product CM (ECG (Holter Monitor), ILR, Event Monitor)), CRM ((Defibrillator (ICD) External (AED)), Pacemaker (CRT P, Dual Chamber Pacemaker)), End User – Global Forecast to 2025

“Cardiac monitoring & cardiac rhythm management devices market is projected to grow at CAGR of 4.0% from 2020 to 2025” The global cardiac monitoring & cardiac rhythm management devices market is projected to reach USD 26.8 billion by 2025 from USD 22.1 billion in 2020, at a CAGR of 4.0% from 2020 to 2025. The growth of this market is driven by the increasing prevalence of cardiovascular diseases; availability of reimbursement for CM & CRM devices; launch of innovative products by market players; increasing investments, funds, and grants for research on CM & CRM devices; and the growing preference for wearable cardiac devices. Also, measures to reduce infections caused due to CIEDs to offer an opportunity for the growth of the market during the forecast period. “......
$4950

Ophthalmic Equipment Market by Product (OCT, Fundus Camera, Ultrasound, Ophthalmoscope, Phoropter, Slit Lamp, Perimeter, Keratometer, Tonometer, IOL, Excimer Laser, OVDs, Phacoemulsification) End User (Hospital, Consumer) – Global Forecast to 2025

“The ophthalmic equipment market is projected to grow at a CAGR of 3.7% during the forecast period.” The global ophthalmic equipment market size is projected to reach USD 63.3 billion by 2025 from USD 52.8 billion in 2020, at a CAGR of 3.7% during the forecast period. The market for ophthalmic equipment is driven primarily by the factors such as the rising geriatric population and prevalence of eye diseases, technological advancements in ophthalmic devices, government initiatives to control visual impairment, and the rising adoption of contact lenses and spectacles. However, the high cost of ophthalmology devices, cuts in the reimbursement for ophthalmic surgical procedures, and the increased adoption of refurbished devices will hinder the overall adoption of ophthalmic equipment an......
$7150

Prefilled Syringes Market by Type [Conventional (Disposable, Reusable), Safety], Material (Glass, Plastic), Design (Single-Chamber, Dual-Chamber, Customized), Application (Diabetes, Cancer, Arthritis, Anaphylaxis, Ophthalmology) – Global Forecast to 2025

“The global prefilled syringes  market is projected to grow at a CAGR of 9.0% during the forecast period” The global prefilled syringes market size is projected to reach USD 8.6 billion by 2025 from USD 5.6 billion in 2020, at a CAGR of 9.0%. The growth in the prefilled syringes market is majorly driven by the rising demand for prefilled syringes is attributed to the growing prevalence of chronic diseases, technological advancements, rising adoption of self-injecting parenteral devices, and supportive government regulations (especially needlestick legislations). In addition, growing awareness on the benefits of prefilled syringes among patients and healthcare professionals, along with the growing number of biologics and biosimilars in the pharmaceuticals market, is supporting the g......
$

Sports Medicine Market by Product (Body Reconstruction, Body Support & Recovery), Application (Knee Injuries, Shoulder Injuries, Foot & Ankle Injuries), End User (Hospitals, Physiotherapy Centers & Clinics) – Analysis & Global Forecast to 2025

“The sports medicine market is projected to grow at a CAGR of 5.7% during the forecast period.” The global sports medicine market is projected to reach USD 7.2 billion by 2025 from USD 5.5 billion in 2020 at a CAGR of 5.7%. Growth in the sports medicine market can be attributed to factors such as the increasing incidence of sports injuries, continuous influx of new products and treatment modalities, developments in the field of regenerative medicine and rising demand for minimally invasive surgeries. However, the high cost of implants and other devices may restrain the market to a certain extent. “The Body Support & Recovery Products segment is expected to grow at the highest rate during the forecast period.” On the basis of product, the global sports medicine market h......
$4950

Veterinary Care Market by Treatment Type (No medicalization, Basic Medicalization, and Under Long Term Veterinary Care), Animal Type (Dogs, Cats, Cattle, Horses, Pigs, and Poultry), and Region – Forecasts to 2025

“Veterinary care market is predicted to foresee exceptional growth in the coming years.” The veterinary care market has experienced considerable growth since the past few years. Market growth can be associated with the introduction of highly efficient veterinary diagnostic tools that enables early disease diagnosis.  The disease diagnosis rate in companion, as well as livestock, has drastically explicitly increased in South East Asian countries. Moreover, veterinary market growth can be traced via the animal health market that is also growing significantly. For instance, Asia Pacific animal health market size is projected to reach ~ USD 23 billion by 2025 from around USD 17 billion in 2018, at a CAGR of 5.2% during the forecast period. The market growth is attributed to the rising ......
$5650

Coronary Guidewires – Medical Devices Pipeline Assessment, 2020

Coronary Guidewires - Medical Devices Pipeline Assessment, 2020 Summary GlobalData's Medical Devices sector report, "Coronary Guidewires - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Coronary Guidewires pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. A coronary guidewire is used to navigate catheters during angiography and Percutaneous Coronary Interventions (PCIs). Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type. Scope - Extensive coverage of the Coronary Guidewires under development - The report reviews details of major pipeline produ......
$2500

Clinical Decision Support Systems – Medical Devices Pipeline Assessment, 2020

Clinical Decision Support Systems - Medical Devices Pipeline Assessment, 2020 Summary GlobalData's Medical Devices sector report, "Clinical Decision Support Systems - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Clinical Decision Support Systems pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Clinical Decision Support Systems (CDSS) are software tools which assist healthcare professionals with decision-making by consolidating a medical knowledge base with patient information to produce case-specific advice. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the ......
$4000

Idiopathic Pulmonary Fibrosis – Epidemiology Forecast to 2029

Idiopathic Pulmonary Fibrosis - Epidemiology Forecast to 2029 Summary Idiopathic pulmonary fibrosis (IPF) is a type of interstitial lung disease and is a serious chronic condition that affects the tissue surrounding the air sacs, or alveoli, in the lungs. This condition occurs when the lung tissue becomes thick and stiff for unknown reasons. Over time, breathing becomes difficult due to fibrosis caused by permanent scarring in the lungs (NHLBI, 2019). IPF is associated with a poor prognosis, with a median survival of three to five years (Raghu et al., 2011). There is currently no cure for IPF. However, certain medicines may slow the progression of IPF, which may extend the lifespan and improve the quality of life for people who have the disease (NHLBI, 2019). GlobalData epidemiologists ......
$3995

Pulmonary Arterial Hypertension – Epidemiology Forecast to 2029

Pulmonary Arterial Hypertension - Epidemiology Forecast to 2029 Summary Pulmonary arterial hypertension (PAH) is a rare, progressive disorder characterized by vascular proliferation and remodeling of the small pulmonary arteries (Humbert et al., 2004; Humbert et al., 2010; Simonneau et al., 2004). In PAH, blood vessels in the lungs are narrowed, blocked, or destroyed. The damage slows blood flow through the lungs (Mayo Clinic, 2020). This results in progressively increasing pulmonary vascular resistance, leading to an increase in pulmonary arterial pressure (Humbert et al., 2004, 2010; Simonneau et al., 2004). GlobalData epidemiologists utilized national databases, registries, and robust peer-reviewed journal articles to build the diagnosed incident and diagnosed prevalent cases of PAH......
$3995

Cardiac Rhythm Management Devices – Medical Devices Pipeline Assessment, 2020

Cardiac Rhythm Management Devices - Medical Devices Pipeline Assessment, 2020 Summary GlobalData's Medical Devices sector report, "Cardiac Rhythm Management Devices - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Cardiac Rhythm Management Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Cardiac Rhythm Management (CRM) devices are those devices which are used to restore the natural synchronized pumping rhythm of the heart. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type. Scope - Extensive coverage of the Cardiac Rhythm Management De......
$4000
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy